<DOC>
	<DOCNO>NCT00145288</DOCNO>
	<brief_summary>Hirsutism presence terminal hair male-like pattern female , due elevate male hormone level . Females hirsutism often overweight metabolism disturbance insulin resistance impair glucose tolerance . The previous study show patient hirsutism ( especially polycystic ovarian syndrome ( PCOS ) ) increase risk develop type 2 diabetes mellitus background insulin resistance / hyperinsulinemia : 30-35 % female PCOS impair glucose tolerance 5-10 % diabetes . Hyperinsulinemia increase risk develop dyslipidemia cardiovascular disease . A previous study department include 340 female hirsutism ( 210 idiopathic hirsutism 134 PCOS ) show 6.6 % diabetes 55 % insulin resistance . There long-term follow study patient hirsutism concern risk develop diabetes . As far , study patient idiopathic hirsutism available . Hirsutism treat low dose oral contraceptive , suppress androgen production . This treatment also influence risk develop diabetes atheromatosis . The previous study show low dose oral contraceptive modest influence lipid profile carbohydrate metabolism patient hirsutism , increase risk develop coronary disease . Aim - To study quantify , patient hirsutime , risk develop type 2 diabetes background insulin resistance / decrease glucose tolerance atheromatosis background insulin resistance / hypercholesterolemia . - To clarify effect P-pills patient hair growth metabolism .</brief_summary>
	<brief_title>Prospective Study Patients With Hirsutism</brief_title>
	<detailed_description>Hirsutism presence terminal hair male-like pattern female , due elevate male hormone level . Females hirsutism often overweight metabolism disturbance insulin resistance impair glucose tolerance . The previous study show patient hirsutism ( especially polycystic ovarian syndrome ( PCOS ) ) increase risk develop type 2 diabetes mellitus background insulin resistance / hyperinsulinemia : 30-35 % female PCOS impair glucose tolerance 5-10 % diabetes ( 1 , 2 , 3 , 4 ) . Hyperinsulinemia increase risk develop dyslipidemia cardiovascular disease ( 5 , 6 , 7 , 8 , 9 ) . A previous study department include 340 female hirsutism ( 210 idiopathic hirsutism 134 PCOS ) show 6.6 % diabetes 55 % insulin resistance ( 10 ) . There long-term follow study patient hirsutism concern risk develop diabetes . As far , study patient idiopathic hirsutism available . Hirsutism treat low dose oral contraceptive , suppress androgen production . This treatment also influence risk develop diabetes atheromatosis . The previous study show low dose oral contraceptive modest influence lipid profile carbohydrate metabolism patient hirsutism , increase risk develop coronary disease ( 11 ) . Aim - To study quantify , patient hirsutime , risk develop type 2 diabetes background insulin resistance / decrease glucose tolerance atheromatosis background insulin resistance / hypercholesterolemia . - To clarify effect P-pills patient hair growth metabolism . Design The patient previously include study between1997 – 2000 ( 231 ) contact order follow . We estimate grad excess hair growth , hormonal metabolism profile . Inclusion criteria The patient include previous study 1997 – 2000 , oral glucose tolerance test include . Exclusion criteria Pregnancy . Investigations Anamnesis : previous treatment , pregnancy / in-utero fertilisation history , family predisposition diabetes cardiovascular disease . Clinical examination : Ferriman–Gallwey score , body mass index ( BMI ) , waist / hip ratio ( WHR ) , blood pressure . Blood analysis : - Metabolism profile ( oral glucose tolerance test , lipid profile ) ; - Hormonal profile ( androgen oestrogen level , prolactin , FH , FSH ) . The ethic aspect We want evaluate effect treatment risk factor influence treatment . All patient receive oral write information study . It emphasise participation voluntary inform consent retract time influence treatment them.The trial validate local ethic committee . The project carry The Endocrinology Department , Odense University Hospital , Denmark , supply technical assistance . Blood analyse founded private found . References 1 . Diamanti-Kandarakis , E. , Baillargeon , J. P. , Iuorno , M. J. , Jakubowicz , D. J. , Nestler , J. E. A modern medical quandary : polycystic ovary syndrome , insulin resistance , oral contraceptive pills.J.Clin.Endocrinol.Metab 2003 88 1927-1932 2 . Arslanian , S. A. , Lewy , V. D. , Danadian , K. Glucose intolerance obese adolescent polycystic ovary syndrome : role insulin resistance beta-cell dysfunction risk cardiovascular disease.J.Clin.Endocrinol.Metab 2001 86 66-71 3 . Ehrmann , D. A. , Barnes , R. B. , Rosenfield , R. L. , Cavaghan , M. K. , Imperial , J . Prevalence impair glucose tolerance diabetes woman polycystic ovary syndrome.Diabetes Care 1999 22 141-146 4 . Palmert , M. R. , Gordon , C. M. , Kartashov , A. I. , Legro , R. S. , Emans , S. J. , Dunaif , A . Screening abnormal glucose tolerance adolescent polycystic ovary syndrome.J.Clin.Endocrinol.Metab 2002 87 1017-1023 5 . Elting , M. W. , Korsen , T. J. , Bezemer , P. D. , Schoemaker , J . Prevalence diabetes mellitus , hypertension cardiac complaint follow-up study Dutch PCOS population.Hum.Reprod . 2001 16 556-560 6 . Loucks , T. L. , Talbott , E. O. , McHugh , K. P. , Keelan , M. , Berga , S. L. , Guzick , D. S. Do polycystic-appearing ovary affect risk cardiovascular disease among woman polycystic ovary syndrome ? Fertil.Steril . 2000 74 547-552 7 . Mather , K. J. , Kwan , F. , Corenblum , B. Hyperinsulinemia polycystic ovary syndrome correlate increase cardiovascular risk independent obesity.Fertil.Steril . 2000 73 150-156 8 . Vrbikova , J. , Cifkova , R. , Jirkovska , A. , Lanska , V. , Platilova , H. , Zamrazil , V. , Starka , L. Cardiovascular risk factor young Czech females polycystic ovary syndrome.Hum.Reprod . 2003 18 980-984 9 . Wild , S. , Pierpoint , T. , McKeigue , P. , Jacobs , H. Cardiovascular disease woman polycystic ovary syndrome long-term follow-up : retrospective cohort study.Clin.Endocrinol . ( Oxf ) 2000 52 595-600 10 . Glintborg , D. , Henriksen , J. E. , Andersen , M. , Hagen , C. , Hangaard , J. , Rasmussen , P. E. , Schousboe , K. , Hermann , A. P. Prevalence endocrine diseases abnormal glucose tolerance test 340 Caucasian premenopausal woman hirsutism referral diagnosis.Fertil.Steril . 2004 82 1570-1579 11 . Creatsas , G. , Koliopoulos , C. , Mastorakos , G. Combined oral contraceptive treatment adolescent girl polycystic ovary syndrome . Lipid profile.Ann.N.Y.Acad.Sci . 2000 900 245-252</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hirsutism</mesh_term>
	<criteria>The patient include previous study 1997 – 2000 , oral glucose tolerance test include . Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>hirsutism</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>polycystic ovary syndrome</keyword>
	<keyword>metabolism</keyword>
</DOC>